Real-world opioid use among patients with migraine enrolled in US commercial insurance and risk factors associated with migraine progression

BACKGROUND: Migraineurs may be categorized as having episodic migraine (EM: < 15 headache days/month) or chronic migraine (CM: ≥ 15 days/month for > 3 months with ≥ 8 days/month having features of migraine). Opioid use has been linked to progression from EM to CM. OBJECTIVE: To describe the ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Qiujun, Rascati, Karen L, Lawson, Kenneth A, Barner, Jamie C, Sonawane, Kalyani B, Rousseau, Justin F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373005/
https://www.ncbi.nlm.nih.gov/pubmed/36282930
http://dx.doi.org/10.18553/jmcp.2022.28.11.1272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373005/
https://www.ncbi.nlm.nih.gov/pubmed/36282930
http://dx.doi.org/10.18553/jmcp.2022.28.11.1272

Ejemplares similares